Home » Fda » What does SECT 505(b)(2) mean in Fda?

SECT 505(b)(2) in Fda Meaning

The SECT 505(b)(2) meaning in Fda terms is "New Drug Application". There are 1 related meanings of the SECT 505(b)(2) Fda abbreviation.

SECT 505(b)(2) on Fda Full Forms

  1. New Drug Application A document whereby a pharmaceutical manufacturer or its agent requests permission from the United States Food and Drug Administration (FDA) for a license to market a drug for one or more specified indications; besides a chemical and pharmacologic description of the drug, the application must show the results of clinical trials conducted with respect to the indication for which a license is requested.

Frequently Asked Questions (FAQ)

  1. What does SECT 505(b)(2) stand for Fda?

    SECT 505(b)(2) stands for New Drug Application in Fda terms.

  2. What is the shortened form of New Drug Application in Fda?

    The short form of "New Drug Application" is SECT 505(b)(2) for Fda.

Citation

SECT 505(b)(2) in Fda. Acronym24.com. (2020, May 24). Retrieved January 3, 2025 from https://acronym24.com/sect-505-b-2-meaning-in-fda/

Last updated